Article
Considerations for diverse RYR1 variants in malignant hyperthermia susceptible patients: a report of two cases.
BMC anesthesiology - 10 Jun 2026
Fang Yan, Mei Wei, Bi Jiangjiang
Abstract excerpt
Malignant hyperthermia (MH) is an autosomal dominant pharmacogenetic disorder primarily triggered by halogenated volatile anesthetics, succinylcholine, or cisatracurium. This report describes two cases exhibiting typical MH symptoms, including hyperthermia, hypercarbia, tachycardia, and acidosis, but with notable differences in the time of onset and symptom severity. The variable expression of MH may be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
